Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
Usman
M
M
Department Of Pathology, The Aga Khan University Hospital, Karachi.
Adil
S N
SN
Sajid
R
R
Khurshid
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced*; D014740:Vidarabine / Q000009:adverse effects* / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D014740:Vidarabine; C024352:fludarabine